Sputnik V vaccine single dose to be less than $10 at international markets

The cost of one dose of the Sputnik V vaccine for international markets will be less than $10. Sputnik V is a ...

November 25, 2020 | Wednesday | News
Korea pushes vaccine R&D for global health

The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to j...

November 24, 2020 | Tuesday | News
Hester Biosciences Nepal unveils live thermo-tolerant PPR vaccine

Hester Nepal recently got the regulatory approval and marketing authorisation from Department of Drug Administration (DD...

November 23, 2020 | Monday | News
CEPI's collaborative task force to assess COVID-19 vaccines on emerging viral strains

To rapidly monitor the emergence of new COVID-19 viral strains and evaluate their impact on vaccine candidates in develo...

November 23, 2020 | Monday | News
Pfizer, BioNTech demonstrate 95% efficacy of COVID-19 vaccine

Pfizer Inc. and BioNTech have announced that, after conducting the final efficacy analysis in their ongoing Ph...

November 23, 2020 | Monday | News
Cytiva supports Clover Biopharma to scale up output of COVID-19 vaccine candidate

US-based Cytiva, a global life sciences leader, is supporting Shanghai-based Clover Biopharmaceuticals, a global clinica...

November 17, 2020 | Tuesday | News
Australia unveils plans for new flu vaccine facility

The Australian government has announced that the largest flu vaccine manufacturing plant in the southern hemisphere will...

November 16, 2020 | Monday | News
South Korea to host production of 150M Sputnik V doses for global distribution

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South ...

November 13, 2020 | Friday | News
Arcturus Therapeutics receives $220M from Singapore for COVID-19 vaccine development

Arcturus Therapeutics Holdings Inc., based in the US, has announced positive interim clinical study results from its ong...

November 12, 2020 | Thursday | News
COVID-19 vaccine candidate by Pfizer, BioNTech shows more than 90% effectivity

Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV...

November 10, 2020 | Tuesday | News
Australia secures further 50M doses of COVID-19 vaccine

Two more COVID-19 vaccines have been secured for the Australian population under new agreements, bringing the Australian...

November 5, 2020 | Thursday | News
Australia reports highest childhood vaccination rates in 2020

On 1 Nov 2020, Australia reported the highest recorded childhood vaccination, with new figures showing four quarters of ...

November 2, 2020 | Monday | News
Takeda expands COVID-19 vaccine supply in Japan

Takeda Pharmaceutical has announced that it will import and distribute 50 million doses of Moderna’s COVID-19...

October 30, 2020 | Friday | News
Moderna announces COVID-19 vaccine supply agreement with Qatar

Moderna Inc. has announced a supply agreement with the Ministry of Public Health of Qatar for mRNA-1273, Moder...

October 29, 2020 | Thursday | News
Russia applies to WHO for vaccine prequalification of Sputnik V

The Russian Direct Investment Fund, (RDIF, Russia's sovereign wealth fund), has submitted applications to...

October 28, 2020 | Wednesday | News
Japan pledges $130M to support global access to COVID-19 vaccines

The global effort to ensure equitable global access to COVID-19 vaccines received a boost with the announcement of a maj...

October 21, 2020 | Wednesday | News
BioNTech, Pfizer to initiate Ph 1/2 trial of COVID-19 mRNA vaccine candidate in Japan

Pfizer Inc. and BioNTech SE on 21 Oct 2020 announced the start of a Phase 1/2 study in Japan for their BN...

October 21, 2020 | Wednesday | News
Thailand triggers production of COVID-19 vaccine for 2021

Thailand Ministry of Public Health, Siam Bioscience, SCG and British-Swedish biopharmaceutical company AstraZeneca has s...

October 19, 2020 | Monday | News